Age (Years) | ||
---|---|---|
Median and range | 67.5 (28–81) | |
Sex (n = 24) | ||
Female | 7 | 29.2% |
Male | 17 | 70.8% |
Histology (n = 24) | ||
Prostate cancer | 11 | 45.8% |
Renal cell carcinoma | 3 | 12.6% |
Urothelial cancer | 2 | 8.3% |
Other* | 8 | 33.3% |
Localization of irradiated metastasis (n = 28) | ||
Spine | 20 | 71.4% |
Rib | 4 | 14.3% |
Other (sternum, femur 2x, sacral bone) | 4 | 14.3% |
Oligometastatic |
||
Oligometastatic disease | 16 | 66.7% |
Diffuse metastatic disease | 8 | 33.3% |
Indication for radiation therapy (n = 24) | ||
Oligometastatic disease | 15 | 62.5% |
Oligoprogression under systemic therapy | 4 | 16.7% |
Radiation resistant histology | 3 | 12.5% |
Intraspinal tumour component | 2 | 8.3% |
Systemic therapy (n = 24) | ||
No systemic therapy | 4 | 16.7% |
Chemotherapy or immunotherapy | 10 | 41.7% |
Hormonal therapy | 10 | 41.7% |